fbpx

Next Consolidation Opportunity in the Ophthalmic Lens Market?

Citing confidential and informed sources, Bloomberg reports that lens giants HOYA and Essilor are sizing up German lens manufacturer Rodenstock GmbH, although no formal sales process is underway.

The company may fetch as much as $557 Million, according to the report. Bridgeport, the firm that acquired Rodenstock in 2006, hired Goldman Sachs to look at strategic options earlier this year. None of the parties provided comment to the reports.

Source:

http://www.bloomberg.com/news/articles/2015-05-11/essilor-hoya-said-to-mull-bids-for-german-lens-maker-rodenstock

2015 Recognition Gala at Cégep Garneau

On Monday, April 27, the Cégep Garneau Foundation and the Department of Visual Orthosis Techniques hosted the 2015 Recognition Gala. “This is the second year that the Foundation and the Department have offered a unique awards ceremony,” explains Darquise Tardif, professor and scholarship partner with colleague Véronique Guay. Six thousand dollars in scholarships were awarded to recipients who distinguished themselves by their perseverance, academic excellence and good management skills.

Other partners also contributed financially to recognize the career paths of these future opticians: Guylaine Michaud, optician, Essilor, Lasik MD, Gestion Opto-Réseau, New Look Eyewear and the Order of Dispensing Opticians of Quebec.

 

 

 

Luxottica Wholesale N.A. Announces New Customer Centric Sales Structure

Luxottica Wholesale North America aims to perfect its commercial structure by creating two dedicated teams, one focused on the Optical market and the other on the Premium Sun market.

Ludo Ladreyt has been appointed to the newly-created role of Senior Vice President, Sales for the N.A. Optical Channel. Ludo most recently served as Vice President of Sales and Marketing for Canada.

All optical customers will now be served under one dedicated and customer-centric sales structure. Reporting to Ludo will be Alessandro Baronti and Nicola Perini (US Independents), Alessandro Lucanto (Key Accounts), Jennifer Brown (Business Development) and the Canadian Independent and Key Account channels.

Leading the further development of the Premium Sun category in N.A., Peter Guthy, will continue as Vice President of Sales for Department Stores.

“This new structure is a natural evolution of our business growth and we believe it will enable us to achieve our long range vision, while improving our service to the market,” said Holly Rush, President of Luxottica Wholesale N.A.

Screen Shot 2015-05-08 at 1.10.16 PM

 

Valeant Names Anne C. Whitaker to New Executive VP and Group Chairman Position

Quebec-based Valeant Pharmaceuticals, Inc., announced that Anne C. Whitaker, formerly of Synta, Sanofi and GlaxoSmithKline, will join Valeant in a newly created position of executive vice president and company group chairman.

Whitaker was recognized for her efforts in prioritizing and streamlining pharmaceutical new product pipeline opportunities.

“Anne is an accomplished pharmaceutical executive with more than 24 years of experience in key leadership roles across health care sales… She also has a proven track record of success in delivering sustainable growth and profitability,” said J. Michael Pearson, Valeant’s chairman and CEO.

The company also announced that Howard B. Schiller, Chief Financial Officer, has advised the Company of his decision to step down once a successor is appointed.  Mr. Schiller will remain in his current position as the search for his replacement proceeds.

http://www.prnewswire.com/news-releases/valeant-announces-cfo-succession-plan-and-additional-executive-appointment-300074020.html

Protein blocking offers new treatment possibilities for AMD

In an article published in the April issue of Nature Medicine, a team of French researchers report that inactivating or blocking the receptors of the protein Slit2 in mice inhibited the growth of faulty retinal blood vessels caused by vasoproliferative diseases such as age-related macular degeneration (AMD). Slit2 is known for its role in the development of nerve connections and is a culprit in the development of certain cancers.

Wet AMD is typically managed with regular injections of antiangiogenic drugs to inhibit the growth of abnormal blood vessels within the retina. These drugs target a specific factor called the vascular endothelial growth factor (VEGF).

New therapies targeting the Slit2 protein will offer benefits for patients suffering from AMD, especially for those who do not respond to the current treatments targeting VEGF.

Further information: http://presse-inserm.fr/en/caring-for-blindness-a-new-protein-in-sight/18933/

 

Featured Posts

Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Learn More
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read more
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read more
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read more
Silmo Paris nouvelle image de marque 2026

SILMO Paris Set to Become the Global Capital of Eyewear and Optics in One Month

SILMO Paris returns 25–28 September, bringing together global eyewear and optical professionals for four days of innovation, trends, conferences and industry dialogue.

Read more
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Learn More
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read More
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read More
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read More
Silmo Paris nouvelle image de marque 2026

SILMO Paris Set to Become the Global Capital of Eyewear and Optics in One Month

SILMO Paris returns 25–28 September, bringing together global eyewear and optical professionals for four days of innovation, trends, conferences and industry dialogue.

Read More
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Learn More
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read more
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read more
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read more
Silmo Paris nouvelle image de marque 2026

SILMO Paris Set to Become the Global Capital of Eyewear and Optics in One Month

SILMO Paris returns 25–28 September, bringing together global eyewear and optical professionals for four days of innovation, trends, conferences and industry dialogue.

Read more
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Learn More
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read more
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read more
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read more
Silmo Paris nouvelle image de marque 2026

SILMO Paris Set to Become the Global Capital of Eyewear and Optics in One Month

SILMO Paris returns 25–28 September, bringing together global eyewear and optical professionals for four days of innovation, trends, conferences and industry dialogue.

Read more